UY23357A1 - Un antigeno de fases sanguineas de plasmodium falciparum, su preparacion y utilizacion - Google Patents

Un antigeno de fases sanguineas de plasmodium falciparum, su preparacion y utilizacion

Info

Publication number
UY23357A1
UY23357A1 UY23357A UY23357A UY23357A1 UY 23357 A1 UY23357 A1 UY 23357A1 UY 23357 A UY23357 A UY 23357A UY 23357 A UY23357 A UY 23357A UY 23357 A1 UY23357 A1 UY 23357A1
Authority
UY
Uruguay
Prior art keywords
plasmodium falciparum
antigen
preparation
falciparum blood
blood phases
Prior art date
Application number
UY23357A
Other languages
English (en)
Inventor
Dagumaa Norute
Berunharuto Kunatsupu
Erika Funto
Hansu Kiyuupaa
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of UY23357A1 publication Critical patent/UY23357A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ADN o secuencia del mismo que codifica la proteína GBP 130 según ID bº 1 (homóloga en alto grado con la proteína que fija una glucoforina), para prepara un medicamento contra Plasmodium falciparum (causante de la malaria en seres humanos). Es de alcance una vacuna que contiene GBP 130 h.
UY23357A 1991-02-21 1992-01-20 Un antigeno de fases sanguineas de plasmodium falciparum, su preparacion y utilizacion UY23357A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105348A DE4105348A1 (de) 1991-02-21 1991-02-21 Ein plasmodium falciparum blutstadien-antigen, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
UY23357A1 true UY23357A1 (es) 1992-01-23

Family

ID=6425521

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23357A UY23357A1 (es) 1991-02-21 1992-01-20 Un antigeno de fases sanguineas de plasmodium falciparum, su preparacion y utilizacion

Country Status (15)

Country Link
EP (1) EP0499834B1 (es)
JP (1) JPH06141868A (es)
KR (1) KR920016593A (es)
AR (1) AR245782A1 (es)
AT (1) ATE173015T1 (es)
AU (1) AU663068B2 (es)
CA (1) CA2061575A1 (es)
DE (2) DE4105348A1 (es)
DK (1) DK0499834T3 (es)
ES (1) ES2129030T3 (es)
GR (1) GR3029265T3 (es)
IE (1) IE920541A1 (es)
MX (1) MX9200711A (es)
UY (1) UY23357A1 (es)
ZA (1) ZA921231B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006737A1 (en) * 1993-09-03 1995-03-09 Kenneth Francis Prendergast Glycophorin binding protein (gbp130) fusion compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004922A1 (en) * 1985-02-20 1986-08-28 Memorial Sloan-Kettering Cancer Center cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS

Also Published As

Publication number Publication date
EP0499834B1 (de) 1998-11-04
MX9200711A (es) 1992-08-01
DE59209544D1 (de) 1998-12-10
DE4105348A1 (de) 1992-09-03
EP0499834A3 (en) 1993-02-17
IE920541A1 (en) 1992-08-26
GR3029265T3 (en) 1999-05-28
DK0499834T3 (da) 1999-07-19
KR920016593A (ko) 1992-09-25
EP0499834A2 (de) 1992-08-26
AU1108192A (en) 1992-08-27
CA2061575A1 (en) 1992-08-22
ES2129030T3 (es) 1999-06-01
JPH06141868A (ja) 1994-05-24
AU663068B2 (en) 1995-09-28
ATE173015T1 (de) 1998-11-15
AR245782A1 (es) 1994-02-28
ZA921231B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
PT815235E (pt) Vacinas para peste
EA199800946A1 (ru) Концентрированный препарат антител
DE68903846T2 (de) Neue galenische form von fenofibrat.
DK52789D0 (da) Avirulente mikrober og anvendelser deraf
GB2255093A (en) Hiv-1 core protein fragments
BR0010823A (pt) Adjuvante de estabilidade, biocompatibilidade otimizada (sba) para realçar a resposta imune humoral e celular
PE97298A1 (es) Composicion para vacunas
DE3583347D1 (de) Klonieren von dna fuer protozoenantigene.
DK183389A (da) Fremgangsmaade til fremstilling af en administrerings- og/eller doseringsform for medicinsk aktive materialer
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
UY23357A1 (es) Un antigeno de fases sanguineas de plasmodium falciparum, su preparacion y utilizacion
BR0207704A (pt) Alfa interferon modificado com imunogenicidade reduzida
ES2054256T3 (es) Fragmentos de peptido de hiv.
AR248046A1 (es) Biosintesis de una secuencia de adn codificante de una glicoproteina inmunogena de hospedantes de garrapatas, sonda de hibridizacion, moleculas de dna, transformantes y plasmidos.
IT1232819B (it) Impiego di sorgenti di nucleobasi per stimolare la funzione immunitaria, relativo procedimento e composizioni farmaceutiche contenenti una tale sorgente di nucleobasi
DE69230106T2 (de) Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
DK56389D0 (da) Forhindring og behandling af retroviralt frembragte sygdomme
DK0493575T3 (da) Vaccine af reassortant rotavirus
DE69130895D1 (de) 16-kDa-OBERFLÄCHENPROTEIN VON P. FALCIPARUM
IT1277926B1 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
BR0207899A (pt) Imunógeno de combinação para administração sequencial dos componentes para evocar uma resposta imune contra o papilomavìrus, produto farmacêutico, uso de um produto farmacêutico, e, método para evocar uma resposta imune contra o papilomavìrus em um paciente
OA08974A (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine